Correlating the metabolic stability of psychedelic 5-HT₂A agonists with anecdotal reports of human oral bioavailability - PubMed (original) (raw)
. 2014 Oct;39(10):2018-23.
doi: 10.1007/s11064-014-1253-y. Epub 2014 Feb 12.
Affiliations
- PMID: 24519542
- DOI: 10.1007/s11064-014-1253-y
Correlating the metabolic stability of psychedelic 5-HT₂A agonists with anecdotal reports of human oral bioavailability
Sebastian Leth-Petersen et al. Neurochem Res. 2014 Oct.
Erratum in
- Neurochem Res. 2014 May;39(5):987
Abstract
2,5-Dimethoxyphenethylamines and their N-benzylated derivatives are potent 5-HT2A agonists with psychedelic effects in humans. The N-benzylated derivatives are among the most selective 5-HT2A agonists currently available and their usage as biochemical and brain imaging tools is increasing, yet very little is known about the relationships between the structure of the ligands and their pharmacokinetic profile. In order to evaluate the potential of these compounds for in vivo applications we have determined the microsomal stability of 11 phenethylamines and 27 N-benzylated derivatives thereof using human liver microsomes. We found that the N-benzylated phenethylamines have much higher intrinsic clearance than the parent phenethylamines. We hypothesize that their low hepatic stability renders them orally inactive due to first pass metabolism, which is supported by anecdotal data from recreational use of these compounds.
Similar articles
- 5-HT2A/5-HT2C Receptor Pharmacology and Intrinsic Clearance of N-Benzylphenethylamines Modified at the Primary Site of Metabolism.
Leth-Petersen S, Petersen IN, Jensen AA, Bundgaard C, Bæk M, Kehler J, Kristensen JL. Leth-Petersen S, et al. ACS Chem Neurosci. 2016 Nov 16;7(11):1614-1619. doi: 10.1021/acschemneuro.6b00265. Epub 2016 Sep 1. ACS Chem Neurosci. 2016. PMID: 27564969 - 4-(Phenylsulfonyl)piperidines: novel, selective, and bioavailable 5-HT(2A) receptor antagonists.
Fletcher SR, Burkamp F, Blurton P, Cheng SK, Clarkson R, O'Connor D, Spinks D, Tudge M, van Niel MB, Patel S, Chapman K, Marwood R, Shepheard S, Bentley G, Cook GP, Bristow LJ, Castro JL, Hutson PH, MacLeod AM. Fletcher SR, et al. J Med Chem. 2002 Jan 17;45(2):492-503. doi: 10.1021/jm011030v. J Med Chem. 2002. PMID: 11784153 - Synthesis and 5-HT1A/5-HT2A receptor activity of N-(4-arylpiperazin-1-yl)alkyl derivatives of 2-azaspiro([4.4]nonane and [4.5]decane-1,3-dione.
Obniska J, Tatarczyńska E, Nikiforuk A, Charakchieva-Minol S, Duszyńska B. Obniska J, et al. Pharmacol Rep. 2006 Jan-Feb;58(1):107-14. Pharmacol Rep. 2006. PMID: 16531637 - Chemistry and Structure-Activity Relationships of Psychedelics.
Nichols DE. Nichols DE. Curr Top Behav Neurosci. 2018;36:1-43. doi: 10.1007/7854_2017_475. Curr Top Behav Neurosci. 2018. PMID: 28401524 Review. - Classics in Neuroimaging: The Serotonergic 2A Receptor System-from Discovery to Modern Molecular Imaging.
T L'Estrade E, Hansen HD, Erlandsson M, Ohlsson TG, Knudsen GM, Herth MM. T L'Estrade E, et al. ACS Chem Neurosci. 2018 Jun 20;9(6):1226-1229. doi: 10.1021/acschemneuro.8b00176. Epub 2018 May 15. ACS Chem Neurosci. 2018. PMID: 29763291 Review.
Cited by
- Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.
Elmore JS, Decker AM, Sulima A, Rice KC, Partilla JS, Blough BE, Baumann MH. Elmore JS, et al. Neuropharmacology. 2018 Nov;142:240-250. doi: 10.1016/j.neuropharm.2018.02.033. Epub 2018 Mar 1. Neuropharmacology. 2018. PMID: 29501528 Free PMC article. - 25CN-NBOMe Metabolites in Rat Urine, Human Liver Microsomes and C. _elegans-_Structure Determination and Synthesis of the Most Abundant Metabolites.
Šuláková A, Nykodemová J, Palivec P, Jurok R, Rimpelová S, Leonhardt T, Šíchová K, Páleníček T, Kuchař M. Šuláková A, et al. Metabolites. 2021 Mar 31;11(4):212. doi: 10.3390/metabo11040212. Metabolites. 2021. PMID: 33807281 Free PMC article. - N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2 Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues.
Nichols DE, Sassano MF, Halberstadt AL, Klein LM, Brandt SD, Elliott SP, Fiedler WJ. Nichols DE, et al. ACS Chem Neurosci. 2015 Jul 15;6(7):1165-75. doi: 10.1021/cn500292d. Epub 2015 Jan 21. ACS Chem Neurosci. 2015. PMID: 25547199 Free PMC article. - Evaluation of Two Novel Hydantoin Derivatives Using Reconstructed Human Skin Model EpiskinTM: Perspectives for Application as Potential Sunscreen Agents.
Słoczyńska K, Popiół J, Gunia-Krzyżak A, Koczurkiewicz-Adamczyk P, Żmudzki P, Pękala E. Słoczyńska K, et al. Molecules. 2022 Mar 12;27(6):1850. doi: 10.3390/molecules27061850. Molecules. 2022. PMID: 35335215 Free PMC article. - Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT₂A receptors, in mice.
Fantegrossi WE, Gray BW, Bailey JM, Smith DA, Hansen M, Kristensen JL. Fantegrossi WE, et al. Psychopharmacology (Berl). 2015 Mar;232(6):1039-47. doi: 10.1007/s00213-014-3739-3. Epub 2014 Sep 17. Psychopharmacology (Berl). 2015. PMID: 25224567 Free PMC article.
References
- J Psychopharmacol. 2008 Aug;22(6):621-32 - PubMed
- ACS Chem Neurosci. 2013 Jan 16;4(1):96-109 - PubMed
- Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):681-93 - PubMed
- J Mass Spectrom. 2005 Jan;40(1):105-16 - PubMed
- Forensic Sci Int. 2005 Mar 10;148(2-3):131-7 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources